NASDAQ · SHCR
Sharecare, Inc.
$1.43-$0.01 (-0.35%)
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
NASDAQ · SNCE · USD
Stock price, earnings
Quote as of Mar 11, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Science 37 Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Science 37 Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Science 37 Holdings, Inc. specializes in providing innovative technology solutions to enable flexible and decentralized clinical trials. Their central platform facilitates modern, digital approaches to clinical research by bringing together all essential parties—including patients, trial investigators, nurses, coordinators, and sponsors—to streamline processes, centralize data generation, and standardize information. Furthermore, the platform integrates specialized networks of patient communities, telemedicine-enabled investigators, mobile nursing professionals, remote coordinators, and connected health devices, all vital for orchestrating adaptable clinical studies. Its highly configurable nature means it can support nearly any phase of a clinical study and a wide range of medical indications. Beyond its direct services, the company also licenses its proprietary, cloud-based technology platform to various life science institutions. Science 37 serves a diverse client base, including major and mid-sized pharmaceutical companies, Contract Research Organizations (CROs), academic institutions, and biotechnology firms. Established in 2014, Science 37 Holdings, Inc. is headquartered in Research Triangle Park, North Carolina.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| $19.28M-1.09% vs estimate |
| Q1 2022 | May 9, 2022 | -$0.18+95.91% vs estimate | $18.69M+24.1% vs estimate |
|---|
| Q4 2021 | Mar 22, 2022 | -$0.60+85.71% vs estimate | $20.38M+37.87% vs estimate |
|---|
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.43-$0.01 (-0.35%)
Sharecare, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
CHF 1.02-CHF 0.05 (-4.67%)
SHL Telemedicine Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.54% below the high.
$0.65-$0.13 (-16.81%)
Rite Aid Corporation’s quoted price sits in the lower half of its reported 52-week range, 91.2% below the high.
$1.10$0.00 (0.0%)
Satsuma Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 86.39% below the high.
$0.43+$0.00 (+0.25%)
Akili, Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.35% below the high.
$0.71+$0.02 (+2.45%)
HEXO Corp.’s quoted price sits in the lower half of its reported 52-week range, 81.49% below the high.
$0.76$0.00 (0.0%)
IsoPlexis Corporation’s quoted price sits in the lower half of its reported 52-week range, 80.17% below the high.
$0.21+$0.01 (+5.66%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 91.37% below the high.
